Skip to main content

Peer Review reports

From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Original Submission
19 Aug 2022 Submitted Original manuscript
5 Sep 2022 Reviewed Reviewer Report - Thin Thin Win
9 Sep 2022 Reviewed Reviewer Report
26 Sep 2022 Author responded Author comments - Jason, Chia-Hsien Cheng
Resubmission - Version 2
26 Sep 2022 Submitted Manuscript version 2
30 Sep 2022 Author responded Author comments - Jason, Chia-Hsien Cheng
Resubmission - Version 3
30 Sep 2022 Submitted Manuscript version 3
6 Oct 2022 Reviewed Reviewer Report
10 Oct 2022 Reviewed Reviewer Report - Thin Thin Win
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Oct 2022 Editorially accepted
21 Oct 2022 Article published 10.1186/s12885-022-10174-6

You can find further information about peer review here.

Back to article page